Answer first
Canada’s Vaping Products Reporting Regulations require specified information to be reported electronically for vaping products intended for retail sale. The rules cover sales reporting, ingredients reporting and notifications when ingredient information changes. A B2B team should identify the product configuration, responsible manufacturer or importer, Canadian market scope and document owner before a product is first sold or a change is released.12
What products are within the VPRR framework?
The Regulations apply to several types of vaping products intended for retail sale, including specified vaping parts, vaping devices with or without a vaping substance, vaping parts containing a vaping substance, vaping substances and specified assortments.2 The detailed scope has exceptions, including for products or assortments subject to an authorization or licence under the Food and Drugs Act.
Health Canada’s overview says that manufacturers and importers in Canada must provide vaping-product sales and ingredients information through prescribed electronic forms.1 The regulation text specifies information manufacturers must submit. Because commercial roles can differ across supply arrangements, every party should obtain qualified Canadian advice on its actual reporting responsibilities rather than rely on a generic title such as supplier, distributor or brand owner.
The reporting system in one view
| Reporting area | What official sources describe | B2B operating question |
|---|---|---|
| Sales report | Sales reporting includes product identification and specified sales information for the covered period. The regulation sets semiannual periods ending 30 June and 31 December, with due dates of 31 July and 31 January respectively.2 | Who owns accurate product, province, return, sales-value and duty records? |
| Ingredients report | An ingredients report is due on or before the day a manufacturer first sells a new covered brand not included in a previous ingredients report.2 | Is the product formula and identifier controlled before first sale? |
| Supplier report | A supplier may submit prescribed information on a manufacturer’s behalf in defined circumstances where more than one substance was used in making an ingredient.2 | Does the supply chain define who provides supporting ingredient information? |
| Change notification | If specified ingredient information changes, a notification is due on or before first sale of a product made in accordance with the change.3 | Does change control stop a revised product before required review and notification? |
The table summarizes the official framework. It is not a substitute for reading the current regulation text and obtaining legal or regulatory advice for a specific product and commercial arrangement.
A B2B responsibility map before release
- Identify the exact product. Record the device, part, pod, cartridge, substance or assortment; its brand, market version and unique product identifier. The Regulations define a unique product identifier as a GTIN or, where there is no GTIN, an alphanumeric code created by the manufacturer that is no more than 10 characters.2
- Identify the reporting party. Record the legal manufacturer, Canadian importer where relevant, Canadian principal place of business, report preparer and qualified adviser. Do not infer roles from commercial titles alone.
- Separate recurring from event-driven work. Treat recurring sales reporting, first-sale ingredients reporting and an ingredient-change notification as different workflow stages.
- Control the source data. Maintain product identifiers, brand information, nicotine concentration where applicable, ingredient information, sales records, return records and provincial market data in a traceable file structure.2
- Authorize changes deliberately. Define who assesses a formula, supplier, concentration or other ingredient-data change; who prepares any notification; and who confirms a product has not been released prematurely.
Sales reporting: why province-level records matter
The regulation text describes sales-report information for each brand, including identification, product type, brand information and, for certain product types, the name of the vaping substance, flavour indication, nicotine concentration and substance volume.2 It also describes information that can include sales and returns by province, throughout Canada and for export, as well as specified value, duty and net-volume information.
For B2B operations, the practical implication is that a sales ledger should not only show units shipped. It should preserve the product version, destination, returns treatment and responsible data owner in a way that can be reconciled. The regulation specifies semiannual reporting periods from 1 January to 30 June and 1 July to 31 December, with due dates of 31 July and 31 January of the following year respectively.2
A team should confirm current deadlines, applicable scope and calculation methods with a qualified adviser, particularly where inventory, returns, export, provincial distribution or excise-duty records are involved.
Ingredients reporting and product change control
For covered vaping products containing a vaping substance, the ingredients report contains brand information and specified ingredient information, including common name, chemical name where applicable, CAS registry number where applicable, supplier name and address, concentration, and a nicotine-source indication if nicotine is used.2 The regulation also describes circumstances in which supplier information may be submitted on a manufacturer’s behalf.
The reporting deadline is operationally important: an ingredients report is due on or before the day the manufacturer first sells a new covered brand not included in a previous report.2 If specified ingredient information changes after the ingredients report is submitted, the prescribed change notification is due on or before first sale of a product manufactured in accordance with the change.3
For this reason, a B2B approval workflow should link formula or ingredient-supplier change control to product release. A new production batch, revised pod substance or rebranded product should not be treated as a simple commercial change without considering whether it affects reportable information.
Electronic forms and record ownership
Health Canada identifies four prescribed forms: the Sales Report for Vaping Products, Ingredients Report for Vaping Products, Supplemental Ingredients Report for Vaping Products (Suppliers) – Ingredients with More than One Substance, and Notification of Change — Vaping Product Ingredients.1 The Regulations state that applicable reports use forms established by the Minister and are attached to an email; forms may be amended from time to time.3
A reliable operating file should document the form version used, official source checked, individual who prepared the report, attestation process and retention location for final submitted copies. The Regulations require reports to include specified manufacturer and preparer contact information, the report date and an attestation that the information is true and complete to the preparer’s knowledge and belief and provided in good faith.2
Questions to resolve before an RFQ becomes a release plan
| Decision area | Question to resolve | Suggested internal owner |
|---|---|---|
| Product identity | Does every covered brand or assortment have a controlled identifier? | Product and regulatory lead |
| Supply-chain role | Who is the manufacturer, importer and Canadian reporting contact? | Legal or regulatory lead |
| Formula records | Are ingredient and supplier records current, traceable and consistent with the market version? | Quality and product lead |
| Sales data | Can sales, returns, destination and relevant duty data be reconciled for the reporting period? | Finance and operations lead |
| Change control | Who approves a formula, supplier or product-data change before first sale? | Quality, regulatory and operations leads |
| Submission file | Where are the current form, report copy, attestation and source record retained? | Document-control owner |
The table is an internal planning framework. Names, roles and responsibilities should be confirmed for the actual legal entity and supply arrangement.
Frequently asked questions
Are the VPRR only about e-liquid ingredients?
No. The Regulations address covered vaping products intended for retail sale and include sales-reporting requirements as well as ingredients reporting for specified product types containing a vaping substance.2 Scope depends on the product and current exceptions.
Are sales reports filed once a year?
No. The regulation sets two reporting periods each year: 1 January–30 June and 1 July–31 December. It identifies due dates of 31 July and 31 January of the following year respectively.2
When is an ingredients report due for a new brand?
The regulation states that the ingredients report is due on or before the day the manufacturer first sells a covered brand that was not included in a previous ingredients report.2
What happens when ingredient information changes?
The regulation requires a notification of change for specified ingredient-information changes after the ingredients report has been submitted. It must be submitted on or before first sale of a product manufactured in accordance with the change.3
Can a supplier provide information on a manufacturer’s behalf?
The regulation describes a defined route in which an ingredient supplier may submit information on a manufacturer’s behalf when more than one substance was used in the manufacture of an ingredient.2 This does not remove the need to identify responsibility and obtain advice for the supply arrangement.
Official sources
- Health Canada — Vaping products regulations, reviewed 23 September 2026.
- Justice Laws Website — Vaping Products Reporting Regulations, SOR/2023-123, page 1, current to 21 July 2026; page modified 11 September 2026; reviewed 23 September 2026.
- Justice Laws Website — Vaping Products Reporting Regulations, SOR/2023-123, page 2, current to 21 July 2026; page modified 11 September 2026; reviewed 23 September 2026.